• LAST PRICE
    3.5400
  • TODAY'S CHANGE (%)
    Trending Up0.2500 (7.5988%)
  • Bid / Lots
    3.4900/ 1
  • Ask / Lots
    3.7700/ 50
  • Open / Previous Close
    3.3400 / 3.2900
  • Day Range
    Low 3.1700
    High 3.5700
  • 52 Week Range
    Low 3.0700
    High 17.4500
  • Volume
    371,428
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3.29
TimeVolumeHUMA
09:32 ET6813.22
09:34 ET11003.2615
09:36 ET5003.22
09:38 ET1003.22
09:39 ET35503.205
09:41 ET1253.23
09:43 ET11003.21
09:45 ET2003.23
09:48 ET8563.235
09:50 ET1003.24
09:52 ET4003.245
09:56 ET3003.26
09:57 ET16093.23
09:59 ET4003.24
10:03 ET2003.26
10:06 ET3213.24
10:08 ET115553.3
10:12 ET20203.32
10:14 ET1003.335
10:15 ET25183.4
10:17 ET2003.385
10:19 ET2323.4
10:21 ET11003.43
10:24 ET10003.437
10:26 ET10283.43
10:28 ET10003.4394
10:32 ET9033.4405
10:35 ET103413.43
10:37 ET264573.41
10:44 ET1003.41
10:46 ET7293.42
10:50 ET12623.44
10:51 ET12073.44
10:55 ET2003.45
10:57 ET2003.45
11:00 ET14293.4761
11:02 ET5003.4599
11:04 ET4503.4419
11:08 ET2503.4494
11:09 ET20003.4752
11:11 ET42913.46
11:13 ET3093.4511
11:15 ET6373.465
11:20 ET1503.4782
11:22 ET6523.48
11:24 ET35003.5
11:26 ET7003.49
11:27 ET34903.49
11:29 ET1003.49
11:31 ET2043.49
11:33 ET5633.48
11:36 ET1003.48
11:42 ET1003.48
11:45 ET15003.5
11:47 ET126883.52
11:49 ET10423.52
11:51 ET11923.5196
12:02 ET1003.54
12:03 ET6003.53
12:05 ET22873.52
12:07 ET5753.518
12:09 ET115333.5
12:12 ET10363.51
12:16 ET19003.5
12:18 ET7003.5
12:20 ET7003.5
12:23 ET655203.525
12:25 ET6063.525
12:27 ET4003.5301
12:30 ET26503.55
12:34 ET4343.53
12:36 ET3473.53
12:39 ET11003.52
12:41 ET74393.5101
12:45 ET36503.49
12:48 ET4003.49
12:56 ET1003.48
12:57 ET6003.48
12:59 ET1003.48
01:03 ET12933.49
01:10 ET3843.5
01:12 ET1003.51
01:14 ET45713.51
01:15 ET1003.5179
01:17 ET4003.51
01:19 ET1003.51
01:21 ET1003.51
01:24 ET4003.51
01:28 ET10583.505
01:30 ET20003.49
01:32 ET4953.49
01:33 ET1003.49
01:37 ET9053.5
01:39 ET6503.5
01:42 ET3003.5
01:44 ET9503.5
01:46 ET1003.5
01:48 ET10003.485
01:50 ET2003.48
01:51 ET1003.48
01:53 ET7633.48
01:55 ET3583.481
01:57 ET2003.48
02:02 ET36003.5196
02:04 ET6003.5
02:06 ET6003.5
02:08 ET6003.495
02:09 ET5033.495
02:11 ET9003.49
02:15 ET1003.49
02:18 ET1003.49
02:20 ET106263.47
02:33 ET11003.4999
02:36 ET6993.5
02:38 ET8373.5
02:40 ET12503.5068
02:42 ET19003.52
02:44 ET7003.515
02:45 ET1003.51
02:49 ET7003.51
02:51 ET1003.51
02:58 ET5003.51
03:02 ET1693.51
03:03 ET14003.5
03:05 ET9003.5
03:09 ET2003.509
03:12 ET25443.495
03:16 ET7003.5
03:20 ET25583.47
03:21 ET4513.49
03:23 ET1003.49
03:25 ET2863.495
03:30 ET1473.495
03:32 ET11003.51
03:34 ET47523.53
03:36 ET17003.53
03:38 ET17253.53
03:39 ET6543.53
03:41 ET1003.53
03:43 ET13003.53
03:45 ET25733.535
03:48 ET8003.54
03:50 ET17343.535
03:52 ET44633.535
03:54 ET11403.535
03:56 ET30793.535
03:57 ET78223.55
03:59 ET234363.54
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHUMA
Humacyte Inc
338.9M
-14.0x
---
United StatesFMTX
Forma Therapeutics Holdings Inc
340.4M
-1.9x
---
United StatesALXO
ALX Oncology Holdings Inc
334.8M
-3.9x
---
United StatesNAUT
Nautilus Biotechnology Inc
332.3M
-6.1x
---
United StatesTYRA
Tyra Biosciences Inc
350.0M
-6.3x
---
United StatesHLVX
Hillevax Inc
351.0M
-2.3x
---
As of 2022-07-05

Company Information

Humacyte, Inc. is engaged in the development and manufacturing of off-the-shelf, universally implantable, bioengineered human tissues. It is developing a portfolio of human acellular vessels (HAVs) with varying diameters and lengths. The HAV cabinet would initially target the vascular repair, reconstruction and replacement market, including vascular trauma; atrioventricular (AV) access for hemodialysis; peripheral arterial disease (PAD); and coronary artery bypass grafting (CABG). The Company has developed a paradigm for manufacturing human tissues that is intended to mimic key aspects of human physiology. It is developing and manufacturing acellular tissues to address life- and limb-threatening vascular conditions while focusing on potential future applications for complex tissue and organ diseases. It is also engaged in developing its HAVs for pediatric heart surgery and the delivery of cellular therapies, including pancreatic islet cell transplantation to treat Type 1 diabetes.

Contact Information

Headquarters
2525 East North Carolina Highway 54DURHAM, NC, United States 27713
Phone
919-313-9633
Fax
302-636-5454

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$338.9M
Revenue (TTM)
$1.3M
Shares Outstanding
103.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.25
Book Value
$1.19
P/E Ratio
-14.0x
Price/Sales (TTM)
252.7
Price/Cash Flow (TTM)
---
Operating Margin
-5,959.58%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.